ADC Therapeutics Company

ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Technology: Atrificial Vectors and Immune Cells
Industry: Healthcare
Headquarters: Lausanne, Vaud, Switzerland
Founded Date: 2011-01-01
Employees Number: 251-500
Funding Status: IPO
Investors Number: 7
Total Funding: 496392274
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-05-17
Last Funding Type: Post-IPO Debt

Visit Website
Register and Claim Ownership